Metformin or thiazolidinedione therapy in PCOS?

Citation metadata

Date: Mar. 2011
From: Nature Reviews Endocrinology(Vol. 7, Issue 3)
Publisher: Nature Publishing Group
Document Type: Clinical report
Length: 1,421 words
Lexile Measure: 1620L

Document controls

Main content

Abstract :

Insulin resistance has a key role in the pathogenesis of polycystic ovary syndrome, a common endocrinopathy that affects young women. Therefore, the use of insulin-sensitizing agents has been studied extensively in this patient population. Given the effectiveness of metformin and thiazolidinediones in previous studies, the question arises: is one class better than the other? Grover, A. & Yialamas, M. A. Nat. Rev. Endocrinol. 7, 128-129 (2011); published online 1 February 2011; doi: 10.1038/nrendo.2011.16

Source Citation

Source Citation   

Gale Document Number: GALE|A250471047